Kidney Survival Impact of Delayed Graft Function Depends on Kidney Donor Risk Index: A Single-Center Cohort Study

por Salguero, Joseba, Chamorro, Laura, Gómez-Gómez, Enrique, de Benito, Patricia, Robles, Jose E., Campos, Juan P.
Publicado 2023

THU550 The Splicing Factor SRSF6 Regulates Androgen Receptor Activity And Represents A Potential Therapeutic Target In Prostate Cancer

por Luque, Raul M, Montero-Hidalgo, Antonio J, Gomez-Gomez, Enrique, Olmos, David, Gahete, Manuel D, Jimenez-Vacas, Juan M
Publicado 2023

Palliative Surgery for Rare Cases of Anterior Urethral Metastasis in Prostate Cancer

por Gómez Gómez, Enrique, Carrasco Aznar, Jose Carlos, Moreno Rodríguez, Maria del Mar, Valero Rosa, José, Requena Tapia, Maria José
Publicado 2014

Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype

por Blanca, Ana, Lopez-Beltran, Antonio, Lopez-Porcheron, Kevin, Gomez-Gomez, Enrique, Cimadamore, Alessia, Bilé-Silva, Andreia, Gogna, Rajan, Montironi, Rodolfo, Cheng, Liang
Publicado 2023

Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer

por Frantzi, Maria, Heidegger, Isabel, Roesch, Marie C., Gomez-Gomez, Enrique, Steiner, Eberhard, Vlahou, Antonia, Mullen, William, Guler, Ipek, Merseburger, Axel S., Mischak, Harald, Culig, Zoran
Publicado 2022

Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients wi...

por Gomez-Gomez, Enrique, Moreno Sorribas, Sara, Valero-Rosa, Jose, Blanca, Ana, Mesa, Juan, Salguero, Joseba, Carrasco-Valiente, Julia, López-Ruiz, Daniel, Anglada-Curado, Francisco José
Publicado 2021

Somatostatin, Cortistatin and Their Receptors Exert Antitumor Actions in Androgen-Independent Prostate Cancer Cells: Critical Role of Endogenous Cortistatin

por Sáez-Martínez, Prudencio, Porcel-Pastrana, Francisco, Pérez-Gómez, Jesús M., Pedraza-Arévalo, Sergio, Gómez-Gómez, Enrique, Jiménez-Vacas, Juan M., Gahete, Manuel D., Luque, Raúl M.
Publicado 2022

Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance

por Salguero, Joseba, Gómez-Gómez, Enrique, Valero-Rosa, José, Carrasco-Valiente, Julia, Mesa, Juan, Martin, Cristina, Campos-Hernández, Juan Pablo, Rubio, Juan Manuel, López, Daniel, Requena, María José
Publicado 2021

CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer

por Frantzi, Maria, Gomez Gomez, Enrique, Blanca Pedregosa, Ana, Valero Rosa, José, Latosinska, Agnieszka, Culig, Zoran, Merseburger, Axel S., Luque, Raul M., Requena Tapia, María José, Mischak, Harald, Carrasco Valiente, Julia
Publicado 2019

Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination

por Frantzi, Maria, Culig, Zoran, Heidegger, Isabel, Mokou, Marika, Latosinska, Agnieszka, Roesch, Marie C., Merseburger, Axel S., Makridakis, Manousos, Vlahou, Antonia, Blanca-Pedregosa, Ana, Carrasco-Valiente, Julia, Mischak, Harald, Gomez-Gomez, Enrique
Publicado 2023

Clinical association of metabolic syndrome, C‐reactive protein and testosterone levels with clinically significant prostate cancer

por Gómez‐Gómez, Enrique, Carrasco‐Valiente, Julia, Campos‐Hernández, Juan Pablo, Blanca‐Pedregosa, Ana Maria, Jiménez‐Vacas, Juan Manuel, Ruiz‐García, Jesus, Valero‐Rosa, Jose, Luque, Raul Miguel, Requena‐Tapia, María José
Publicado 2018

LRP10, PGK1 and RPLP0: Best Reference Genes in Periprostatic Adipose Tissue under Obesity and Prostate Cancer Conditions

por Pérez-Gómez, Jesús M., Porcel-Pastrana, Francisco, De La Luz-Borrero, Marina, Montero-Hidalgo, Antonio J., Gómez-Gómez, Enrique, Herrera-Martínez, Aura D., Guzmán-Ruiz, Rocío, Malagón, María M., Gahete, Manuel D., Luque, Raúl M.
Publicado 2023

Comparative Cytotoxic Activity of Hydroxytyrosol and Its Semisynthetic Lipophilic Derivatives in Prostate Cancer Cells

por León-González, Antonio J., Sáez-Martínez, Prudencio, Jiménez-Vacas, Juan M., Herrero-Aguayo, Vicente, Montero-Hidalgo, Antonio J., Gómez-Gómez, Enrique, Madrona, Andrés, Castaño, Justo P., Espartero, José L., Gahete, Manuel D., Luque, Raúl M.
Publicado 2021

Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng...

por Gomez Gomez, Enrique, Salamanca Bustos, Juan José, Carrasco Valiente, Julia, Fernandez Rueda, Jose Luis, Blanca, Ana, Valero Rosa, José, Bravo Arrebola, Ines, Marquez López, Javier, Jimenez Vacas, Juan Manuel, Luque, Raul Miguel, Requena Tapia, Maria José
Publicado 2019

Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer

por Sáez-Martínez, Prudencio, Jiménez-Vacas, Juan M., León-González, Antonio J., Herrero-Aguayo, Vicente, Montero Hidalgo, Antonio J., Gómez-Gómez, Enrique, Sánchez-Sánchez, Rafael, Requena-Tapia, María J., Castaño, Justo P., Gahete, Manuel D., Luque, Raúl M.
Publicado 2020

Telomere-based risk models for the early diagnosis of clinically significant prostate cancer

por Rubio Galisteo, Juan Manuel, Fernández, Luis, Gómez Gómez, Enrique, de Pedro, Nuria, Cano Castiñeira, Roque, Pedregosa, Ana Blanca, Guler, Ipek, Carrasco Valiente, Julia, Esteban, Laura, González, Sheila, Castelló, Nila, Otero, Lissette, García, Jorge, Segovia, Enrique, Requena Tapia, María José, Najarro, Pilar
Publicado 2020

The management of active surveillance in prostate cancer: validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Regist...

por Borque-Fernando, Ángel, Rubio-Briones, José, Esteban, Luis Mariano, Collado-Serra, Argimiro, Pallás-Costa, Yoni, López-González, Pedro Ángel, Huguet-Pérez, Jorge, Sanz-Vélez, José Ignacio, Gil-Fabra, Jesús Manuel, Gómez-Gómez, Enrique, Quicios-Dorado, Cristina, Fumadó, Lluis, Martínez-Breijo, Sara, Soto-Villalba, Juan
Publicado 2017

Plasma ghrelin O‐acyltransferase (GOAT) enzyme levels: A novel non‐invasive diagnosis tool for patients with significant prostate cancer

por Gómez‐Gómez, Enrique, Jiménez‐Vacas, Juan M., Carrasco‐Valiente, Julia, Herrero‐Aguayo, Vicente, Blanca‐Pedregosa, Ana M., León‐González, Antonio J., Valero‐Rosa, José, Fernández‐Rueda, José L., González‐Serrano, Teresa, López‐Miranda, José, Gahete, Manuel D., Castaño, Justo P., Requena‐Tapia, María J., Luque, Raúl M.
Publicado 2018

Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer

por Jiménez-Vacas, Juan M., Gómez-Gómez, Enrique, Montero-Hidalgo, Antonio J., Herrero-Aguayo, Vicente, L-López, Fernando, Sánchez-Sánchez, Rafael, Guler, Ipek, Blanca, Ana, Méndez-Vidal, María José, Carrasco, Julia, Lopez-Miranda, José, Requena-Tapia, María J., Castaño, Justo P., Gahete, Manuel D., Luque, Raúl M.
Publicado 2019